2m 2m 2m 2m 2m 2m 2m
- $12.5BMarket Cap
- 3.13%1-Year Change
- Medical DevicesIndustry
Smith&Nephew Sp ADR (SNN)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 40
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
The global wound irrigation systems market is projected to grow from USD 307.87 million in 2025 to USD 430.05 million by 2035, with a CAGR of 3.55%. Growth is driven by rising chronic wound prevalence, increased surgical volumes, and innovations in pulsatile lavage systems. North America leads with 40% market share, while Asia Pacific shows the fastest growth at 4.7% CAGR. Manual systems currently dominate with 53% market share, though battery-operated systems are expected to grow fastest.
06/03/2026, 7:00 AM • GlobeNewswire
Smith+Nephew announced the US launch of its next generation LEAF Patient Monitoring System, a cloud-based platform designed to prevent hospital-acquired pressure injuries (HAPIs). The system uses wearable sensors to monitor patient mobility and improve turning protocol adherence. According to the company, the LEAF system monitors over 150,000 patients annually, reduces HAPI odds by up to 73%, and delivers up to $1.8 million in estimated savings per critical care facility.
06/01/2026, 3:00 PM • GlobeNewswire
Smith+Nephew is launching two new wound care products at the European Wound Management Association Conference in May 2026: ALLEVYN COMPLETE CARE Foam Dressing with enhanced exudate management and pressure ulcer prevention, and RENASYS EDGE Negative Pressure Wound Therapy System designed for simplicity and patient compliance. The launches address the significant healthcare challenge of chronic wounds affecting 14.9 million people in Europe.
05/05/2026, 1:00 PM • GlobeNewswire
The global wound cleanser products market is valued at USD 3.22 billion in 2025 and is projected to reach USD 5.17 billion by 2035, growing at a CAGR of 4.92%. Growth is driven by rising chronic wounds, surgical procedures, and demand for advanced antimicrobial cleansing solutions. The U.S. market is expected to grow from USD 0.99 billion to USD 1.49 billion during the same period. Saline-based cleansers dominate with 37.55% market share, while antimicrobial cleansers are expected to grow fastest at 6.18% CAGR.
05/01/2026, 6:00 AM • GlobeNewswire
The global tissue engineering market is projected to grow from USD 15.01 billion in 2026 to USD 27.59 billion by 2031, driven by advancements in regenerative medicine, biomaterials, and stem cell research. Key growth drivers include increasing demand for regenerative therapies, innovations in 3D bioprinting, rising prevalence of chronic diseases, and expanding applications in orthopedics, skin regeneration, and dental restoration. North America leads the market while Asia-Pacific emerges as a high-growth region.
04/24/2026, 3:54 AM • GlobeNewswire
The global surgical drill bits market was valued at USD 316 million in 2025 and is projected to reach USD 540 million by 2035, growing at a CAGR of 5.5%. Growth is driven by healthcare infrastructure development in emerging economies, increased surgical procedures, and rising demand for infection prevention measures. Hospitals are expected to dominate the market segment, while North America leads in market share and Asia-Pacific shows the highest growth rate.
04/21/2026, 12:30 AM • GlobeNewswire
The global foot and ankle devices market is projected to grow from USD 5.9 billion in 2025 to USD 9.2 billion by 2034, driven by rising incidence of foot and ankle conditions, diabetes-related complications, aging populations, and technological advancements in minimally invasive procedures and 3D-printed implants. North America leads the market, with key players including DePuy Synthes, Stryker, and Zimmer Biomet driving innovation through recent product launches and strategic developments.
04/20/2026, 1:00 PM • GlobeNewswire
Ambulatory Surgical Equipment Market to Reach USD 14.58 Billion, Rising at 7.85% by 2035
The global ambulatory surgical equipment market is valued at USD 7.39 billion in 2026 and is expected to reach USD 14.58 billion by 2035, growing at a 7.85% CAGR. North America dominates with 34% market share, while Asia Pacific is the fastest-growing region. Endoscopy and laparoscopy systems lead by product type at 18% share, with compact intraoperative imaging expected to grow fastest. Independent ambulatory surgical centers account for 42% of the market.
04/16/2026, 10:00 AM • GlobeNewswire
The global surgical stapling devices market was valued at USD 5.47 billion in 2025 and is projected to reach USD 10.14 billion by 2035, growing at a 7.2% CAGR. Growth is driven by increasing surgical volumes, adoption of minimally invasive and robotic procedures, rising obesity and colorectal disease prevalence, and technological innovations in powered stapling systems. North America leads the market while Asia Pacific shows the fastest growth.
03/17/2026, 11:30 PM • GlobeNewswire
Smith+Nephew announced it will showcase advanced orthopaedic technologies at AAOS 2026, including its CORI handheld robotic surgical system for hip, knee and shoulder arthroplasty, new trauma solutions like the EVOS plating system, and an expanded ASC portfolio. The company also announced distribution agreements with SI-BONE for pelvic fracture solutions and RMR Ortho for nitinol fixation technology.
03/03/2026, 1:00 PM • GlobeNewswire
Smith+Nephew will showcase its rotator cuff repair portfolio at AAOS 2026, featuring the newly acquired Tendon Seam Repair System and REGENETEN Bioinductive Implant. The company also announced exclusive US distribution agreements with RMR Ortho for A'TOMIC nitinol fixation technology and SI-BONE for their iFuse TORQ portfolio, expanding its orthopedic offerings.
03/02/2026, 1:00 PM • GlobeNewswire
The global scar treatment market is projected to grow from USD 26.60 billion in 2025 to USD 56.30 billion by 2033, with a CAGR of 9.91%. Growth is driven by increasing awareness of advanced cosmetic and reconstructive procedures, rising prevalence of acne, surgical, and traumatic scars, and technological advancements in minimally invasive treatments. The U.S. market alone is expected to reach USD 17.69 billion by 2033.
02/18/2026, 4:00 AM • GlobeNewswire
The global anti-biofilm agents market is experiencing robust growth driven by escalating hospital-acquired infections (13% higher than pre-pandemic levels), rising antimicrobial resistance, and increasing prevalence of chronic wounds among the 589 million diabetic population. Key growth drivers include FDA regulatory support, industrial water treatment demand, and hospital adoption of advanced biofilm-disrupting technologies. Dressings and silver-based solutions dominate the market, with North America leading regionally and Asia Pacific showing fastest growth.
02/10/2026, 4:51 AM • GlobeNewswire
The global orthopedic implants market is projected to grow from USD 23.50 billion in 2025 to USD 33.20 billion by 2033, expanding at a CAGR of 4.43%. Growth is driven by rising musculoskeletal disorders, aging populations, technological advancements in biomaterials and minimally invasive procedures, and digital orthopedic solutions. However, high implant costs, strict regulatory requirements, and pricing pressures from healthcare providers remain key challenges.
02/06/2026, 6:00 AM • GlobeNewswire
The global surgical staplers market is projected to grow from USD 6.41 billion in 2025 to USD 10.87 billion by 2033, at a CAGR of 6.87%. Growth is driven by increasing surgical volumes, adoption of minimally invasive procedures, and technological advancements in powered and disposable stapling systems. However, high device costs and stringent regulatory requirements pose challenges to market expansion.
02/06/2026, 3:34 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Key Executives
- Deepak S. Nath
- John Terence Rogers
- Charles Reynolds
- Elga Lohler
- Alison Parkes
Current Ownership Distribution
- Institutions657.7M (83.51%)
- Mutual Funds129.9M (16.49%)
- Insiders0 (0.00%)
- Other0 (0.00%)